ProfileGDS4132 / 227607_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 38% 43% 43% 46% 45% 49% 44% 41% 40% 44% 34% 27% 34% 40% 39% 42% 40% 38% 33% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10199.002538
GSM201543Muscle PCOS pioglitazone 121103.23443
GSM201544Muscle PCOS pioglitazone 161114.21843
GSM201545Muscle PCOS pioglitazone 201131.00646
GSM201829Muscle PCOS pioglitazone 231125.56845
GSM201830Muscle PCOS pioglitazon 251136.34949
GSM201831Muscle PCOS pioglitazone 271117.17944
GSM201832Muscle PCOS pioglitazone 31104.09241
GSM201833Muscle PCOS pioglitazone 4198.088740
GSM201834Muscle PCOS pioglitazone 81112.63844
GSM201835Muscle PCOS after pioglitazone 10272.607534
GSM201836Muscle PCOS after pioglitazone 12254.265927
GSM201837Muscle PCOS after pioglitazone 16270.940734
GSM201838Muscle PCOS after pioglitazone 20294.402940
GSM201839Muscle PCOS after pioglitazone 23293.765539
GSM201840Muscle PCOS after pioglitazone 252105.73642
GSM201841Muscle PCOS after pioglitazone 27288.57440
GSM201842Muscle PCOS after pioglitazone 3279.430338
GSM201843Muscle PCOS after pioglitazone 4281.781933
GSM201844Muscle PCOS after pioglitazone 8297.528640